Loading…
Axolabs is an integrated CRO and CDMO for nucleic acid therapeutics, offering services from discovery and preclinical development through clinical and commercial cGMP manufacturing. The company provides lead identification, bioanalytics, process development, and scalable production of oligonucleotides and RNA-based therapeutics.
AI named Axolabs in January 2026.